PCOS Diagnostic Market to be Dominated by the Transvaginal Ultrasound Segment by 2028
Increasing
prevalence of PCOS among women is expected to drive Global PCOS Diagnostic
Market in the forecast period, 2024-2028.
According to TechSci Research report, “PCOS Diagnostic Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F”, the Global PCOS Diagnostic Market is
anticipated to grow at a steady rate in the forecast period, 2024-2028. This can be ascribed to the growing
number of PCOS cases across the world. PCOS
is the most common endocrine disorder among the women of reproductive age
(15-49 years). According to the Centers for Disease Control & Prevention
(CDC) May 2022, PCOS is the most common cause of infertility among women.
The National Institute of Child Health and Human Development (NICHD)/National
Institutes of Health (NIH)/European Society of Human Reproduction and
Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM)
accompanied by the Androgen Excess Society (AES) Criteria (2006)
provided a diagnostic criterion for PCOS including Hyperandrogenism,
Oligo-ovulation/anovulation, Polycystic ovaries and exclusion of other related
disorders, as factors to be met for the diagnosis of PCOS.
Besides, sudden outbreak and spread of pandemic COVID-19 has increased the
count for PCOS patients, as it is a symptomatic illness, the
physical and mental health of women affected by the COVID-19 epidemic and the
associated lockdown procedures was highly grown more negative. Therefore, the
pandemic and its associated restrictions had a disproportionately negative
effect on women who typically received care from various main and specialist
healthcare facilities.
One of the primary factors driving the market expansion in North America is the
rise in PCOS cases, caused by the prevalence of obesity and overweight people. Obesity,
being considered a major risk factor for PCOS, has seen a surge during the
pandemic. According to a report (September 2020) supplied by the Centers for
Disease Control and Prevention (CDC), adult obesity prevalence is rising as a
result of work-from-home culture, a decline in physical activity, and adult
population stress. The data by CDC
revealed that there is a high prevalence of obesity in North American countries
(~35%), which is going to increase the risk of PCOS and is anticipated to offer
growth to the market.
Also, there have been several initiatives by private and government firms to
increase awareness about the disease, which is also expected to drive the
market. For instance, on 30th April,
2016, in India, National Institute for Research in Reproductive Health (NIRRH)
inaugurated a multidisciplinary clinic_ PCOS Clinic. The PCOS clinic - is first
of its kind in India, it is inaugurated as a support from the Government of
India and is currently serving as a common platform where services
and research meet. In the center, women with PCOS will receive holistic
management from a multidisciplinary team of infertility specialists,
dermatologists, psychiatrists, nutritionists, and yoga instructors.
However, this high incidence and its connection to ovulation and menstruation
abnormalities, infertility, hair loss, and metabolic difficulties emphasize the
significant financial burden caused by PCOS and could therefore restrain the
global PCOS diagnostic market over the course of the projected period.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "PCOS Diagnostic Market"
Global PCOS Diagnostic
Market can be segmented by the type of test, by end user and by region.
Based on Test Type Channel, the Global PCOS Diagnostic Market can be segmented into Blood Test, Pelvic Exam and Ultrasound (Transvaginal). The Transvaginal Ultrasound segment dominated the market in 2022. This was due to ultrasound being the most acceptable test to be performed to get a clear idea of the PCOS affected ovarian morphology by capturing an ultrasound image of the vagina and thereby enabling the patient for further treatment. Besides, the transvaginal ultrasound provides an ultrasound image of a woman's uterus, ovaries, tubes, cervix and pelvic area and thus, can be used for acknowledging the health and degree of illness among the organs, thus analyzing the PCOS prevalence status.
Based on end user, the Global PCOS Diagnostic Market can be segmented into hospital & clinics, fertility clinics, and others. The hospital & clinics segment is dominating the market in 2022 and will maintain its dominance throughout the forecast period. This can be attributed to the growing number of patient admissions in these facilities suffering from various symptoms leading to PCOS. Generally, patients’ traction is more in Hospitals & Clinics as most women suffering from symptoms related to PCOS, visit common physicians, dermatologists, endocrinologists, infertility experts and gynecologists available in the Hospital & Clinics premises for the diagnosis.
Major companies operating in the Global
PCOS Diagnostic Market are:
- Siemens Healthineers AG
- GE Healthcare
- Mindray Medical International Limited
- Esaote S.p.A
- Telemed Medical Systems
- Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
- BK Medical
- Alpinion Medical Systems
- Mindray ZONARE Medical Systems
- Xianfeng Ultrasound Medical
Companies operating in the market are
following strategies such as continuously innovating tools to improve image
quality and create specialized clinical tools to help the patients see more
anatomical detail with greater certainty, enabling them to provide the best
possible patient care, in order to stay competitive and have an edge over other
players operating in the industry.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate in the Global PCOS Diagnostic Market during the
forecast period on account of increasing prevalence of PCOS. Besides,
increasing healthcare expenditure and flourishing healthcare industry in the
region are further expected to support the market growth in the region” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“PCOS Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Blood Test, Pelvic Exam, Ultrasound Transvaginal)), By End User (Hospital & Clinics, Fertility Clinics, Others),
and CompetitionBy Region”, has
evaluated the future growth potential of Global PCOS Diagnostic Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global PCOS diagnosis market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com